Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

被引:899
作者
Doitsh, Gilad [1 ]
Galloway, Nicole L. K. [1 ]
Geng, Xin [1 ]
Yang, Zhiyuan [1 ]
Monroe, Kathryn M. [1 ]
Zepeda, Orlando [1 ]
Hunt, Peter W. [2 ]
Hatano, Hiroyu [2 ]
Sowinski, Stefanie [1 ]
Munoz-Arias, Isa [1 ]
Greene, Warner C. [1 ,2 ,3 ]
机构
[1] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; EX-VIVO; DENDRITIC CELLS; LYMPHOID-TISSUE; APOPTOSIS; ACTIVATION; INHIBITORS; MATURATION; IL-1-BETA; MONOCYTES;
D O I
10.1038/nature12940
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The pathway causing CD4 T-cell death in HIV-infected hosts remains poorly understood although apoptosis has been proposed as a key mechanism. We now show that caspase-3-mediated apoptosis accounts for the death of only a small fraction of CD4 T cells corresponding to those that are both activated and productively infected. The remaining over 95% of quiescent lymphoid CD4 T cells die by caspase-1-mediated pyroptosis triggered by abortive viral infection. Pyroptosis corresponds to an intensely inflammatory form of programmed cell death in which cytoplasmic contents and pro-inflammatory cytokines, including IL-1 beta, are released. This death pathway thus links the two signature events in HIV infection-CD4 T-cell depletion and chronic inflammation-and creates a pathogenic vicious cycle in which dying CD4 T cells release inflammatory signals that attract more cells to die. This cycle can be broken by caspase 1 inhibitors shown to be safe in humans, raising the possibility of a new class of 'anti-AIDS' therapeutics targeting the host rather than the virus.
引用
收藏
页码:509 / +
页数:18
相关论文
共 69 条
  • [51] CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue
    Penn, ML
    Grivel, JC
    Schramm, B
    Goldsmith, MA
    Margolis, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (02) : 663 - 668
  • [52] PERREGAUX D, 1992, J IMMUNOL, V149, P1294
  • [53] PERREGAUX D, 1994, J BIOL CHEM, V269, P15195
  • [54] Innate Antiviral Response: Role in HIV-1 Infection
    Pitha, Paula M.
    [J]. VIRUSES-BASEL, 2011, 3 (07): : 1179 - 1203
  • [55] ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs
    Randle, JCR
    Harding, MW
    Ku, G
    Schonharting, M
    Kurrle, R
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (07) : 1207 - 1209
  • [56] Apoptosis: The importance of being eaten
    Ren, Y
    Savill, J
    [J]. CELL DEATH AND DIFFERENTIATION, 1998, 5 (07) : 563 - 568
  • [57] Correlates of apoptosis of CD4+ and CD8+ T cells in tonsillar tissue in HIV type 1 infection
    Rosok, BI
    Brinchmann, JE
    Stent, G
    Bjerknes, R
    Voltersvik, P
    Olofsson, J
    Åsjö, B
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (18) : 1635 - 1643
  • [58] Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
    Sallusto, F
    Lenig, D
    Förster, R
    Lipp, M
    Lanzavecchia, A
    [J]. NATURE, 1999, 401 (6754) : 708 - 712
  • [59] Antiviral actions of interferons
    Samuel, CE
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2001, 14 (04) : 778 - 809
  • [60] The Inflammasomes
    Schroder, Kate
    Tschopp, Jurg
    [J]. CELL, 2010, 140 (06) : 821 - 832